Literature DB >> 28968364

Chronic Demyelinating Polyneuropathies.

Jeffrey A Allen.   

Abstract

PURPOSE OF REVIEW: This article reviews the chronic demyelinating neuropathies, with a focus on the diagnosis and treatment of immune-mediated neuropathies and the features that can help differentiate immune-mediated neuropathies from other chronic demyelinating peripheral nerve conditions. RECENT
FINDINGS: Advances in clinical phenotyping and outcomes assessment have enabled neurologists to improve disease recognition, treatment, and disease monitoring. Our understanding of the immunopathogenesis of demyelinating neuropathies is evolving. Identification of new antibodies and recognition that node of Ranvier dysfunction may be an early pathogenic feature may herald further diagnostic and treatment advancements.
SUMMARY: The chronic demyelinating polyneuropathies are heterogeneous. The clinical and diagnostic features are sometimes overlapping, and the specific disorders are variable in pathogenesis, treatment, and prognosis. This heterogeneity underscores the importance of achieving diagnostic accuracy and implementing disease-specific treatment approaches.

Entities:  

Mesh:

Year:  2017        PMID: 28968364     DOI: 10.1212/CON.0000000000000517

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  5 in total

Review 1.  Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies.

Authors:  Jolien Wolbert; Mandy I Cheng; Gerd Meyer zu Horste; Maureen A Su
Journal:  JCI Insight       Date:  2020-02-13

2.  Spinal canal decompression for hypertrophic neuropathy of the cauda equina with chronic inflammatory demyelinating polyradiculoneuropathy: A case report.

Authors:  Lei Ye; Wei Yu; Nai-Zheng Liang; Ying Sun; Li-Fen Duan
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

Review 3.  Treatment Approaches for Atypical CIDP.

Authors:  Deepak Menon; Hans Dieter Katzberg; Vera Bril
Journal:  Front Neurol       Date:  2021-03-15       Impact factor: 4.003

4.  Evaluation and enhancement of standard equations for renal function estimation in individuals with components of metabolic disease.

Authors:  Luigi Brunetti; Hyunmoon Back; Sijia Yu; Urma Jalil; Leonid Kagan
Journal:  BMC Nephrol       Date:  2021-11-22       Impact factor: 2.388

Review 5.  The Misdiagnosis of CIDP: A Review.

Authors:  Jeffrey A Allen
Journal:  Neurol Ther       Date:  2020-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.